Bevacizumab plus interferon alpha in patients with metastatic renal cell carcinoma.
Division of Medical Oncology and Experimental Therapeutics, City of Hope Cancer Center, Duarte, CA 91010, USA.
Przemyslaw
P
Twardowski
Robert A
RA
Figlin